Trademark: 88020634
Status Date
Tuesday, March 14, 2023
Registration Number
7000700
Registration Date
Tuesday, March 14, 2023
Filing Date
Friday, June 29, 2018
Published for Opposition
Tuesday, January 14, 2020
5 Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases
1 Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use
Mar 14, 2023
Notice Of Registration Confirmation Emailed
Mar 14, 2023
Registered-Principal Register
Feb 10, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 9, 2023
Allowed Principal Register - Sou Accepted
Feb 2, 2023
Statement Of Use Processing Complete
Jan 31, 2023
Use Amendment Filed
Jan 31, 2023
Teas Statement Of Use Received
Jan 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2023
Sou Extension 5 Granted
Dec 15, 2022
Sou Extension 5 Filed
Jan 4, 2023
Case Assigned To Intent To Use Paralegal
Dec 15, 2022
Sou Teas Extension Received
Jun 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2022
Sou Extension 4 Granted
Jun 14, 2022
Sou Extension 4 Filed
Jun 14, 2022
Sou Teas Extension Received
Dec 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2021
Sou Extension 3 Granted
Dec 16, 2021
Sou Extension 3 Filed
Dec 16, 2021
Sou Teas Extension Received
May 18, 2021
Notice Of Approval Of Extension Request E-Mailed
May 14, 2021
Sou Extension 2 Granted
May 14, 2021
Sou Extension 2 Filed
May 14, 2021
Sou Teas Extension Received
Dec 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 22, 2020
Sou Extension 1 Granted
Dec 22, 2020
Sou Extension 1 Filed
Dec 22, 2020
Sou Teas Extension Received
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 4, 2020
Extension Of Time To Oppose Process - Terminated
Feb 13, 2020
Extension Of Time To Oppose Received
Jan 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2020
Published For Opposition
Dec 25, 2019
Notification Of Notice Of Publication E-Mailed
Dec 11, 2019
Assigned To Lie
Dec 9, 2019
Approved For Pub - Principal Register
Nov 20, 2019
Teas/Email Correspondence Entered
Nov 19, 2019
Correspondence Received In Law Office
Nov 19, 2019
Teas Request For Reconsideration Received
May 20, 2019
Notification Of Final Refusal Emailed
May 20, 2019
Final Refusal E-Mailed
May 20, 2019
Final Refusal Written
Apr 30, 2019
Teas/Email Correspondence Entered
Apr 29, 2019
Correspondence Received In Law Office
Apr 29, 2019
Teas Response To Office Action Received
Oct 29, 2018
Notification Of Non-Final Action E-Mailed
Oct 29, 2018
Non-Final Action E-Mailed
Oct 29, 2018
Non-Final Action Written
Oct 22, 2018
Assigned To Examiner
Jul 5, 2018
New Application Office Supplied Data Entered
Jul 3, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
